⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10794340 | 0.92 | FUCA1 (0.30) | — | |
| SCHEMBL8024156 | 0.85 | — | — | |
| SCHEMBL770374 | 0.85 | — | — | |
| SCHEMBL10985092 | 0.85 | — | — | |
| SCHEMBL9679797 | 0.85 | — | — | |
| SCHEMBL24245452 | 0.85 | CA1 (0.45) | — | |
| Hydrochloric Acid SCHEMBL1032687 | 0.82 | CA1 (0.36) | — | |
| SCHEMBL11048816 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL8019492 | 0.82 | CA1 (0.36) | — | |
| SCHEMBL11027152 | 0.82 | FUCA1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022268906-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2022-12-29 | — | — | WO | disclosed |
| US-20090054697-A1 | METHOD FOR PRODUCING UNSATURATED ETHER COMPOUND | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1876163-A1 | METHOD FOR PRODUCING UNSATURATED ETHER COMPOUND | Kyowa Hakko Chemical Co., Ltd. (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-20050154061-A1 | peroxisome-proliferator-activated receptor (PPAR)-delta agonist; 2-[4-[[[2-[(2,4-Dichlorophenyl)amino]-2-oxoethyl]cyclohexylamino]methyl]-2-methylphenoxy]-2-methylpropanoic acid; cardiovascular disorders, dyslipidaemias or restenosis; improves HDL/LDL cholesterol ratio; side effect reduction | BAYER AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | US | disclosed |
| EP-1438285-A1 | ACETIC ACID DERIVATIVES | Bayer HealthCare AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035603-A1 | ACETIC ACID DERIVATIVES | BAYER HEALTHCARE AG (DE) | 2003-05-01 | — | — | WO | disclosed |
| US-4510097-A | Hindered aliphatic monoisocyanates | W. R. GRACE & CO. (US) | 1985-04-09 | — | — | US | disclosed |